BioCryst Pharmaceuticals shares owned by Grimes & Company
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Grimes & Company
from 13F filings
Historical chart of Grimes & Company investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Grimes & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $363k | 71k | 5.08 |
| 2023-12-31 | $433k | 72k | 5.99 |
| 2023-09-30 | $521k | 74k | 7.08 |
| 2023-06-30 | $512k | 73k | 7.04 |
| 2023-03-31 | $603k | 72k | 8.34 |
| 2022-12-31 | $826k | 72k | 11.48 |
| 2022-09-30 | $907k | 72k | 12.61 |
| 2022-06-30 | $751k | 71k | 10.58 |
| 2022-03-31 | $1.1M | 69k | 16.26 |
| 2021-12-31 | $907k | 66k | 13.85 |
| 2021-09-30 | $757k | 53k | 14.37 |
| 2021-06-30 | $800k | 51k | 15.81 |
| 2021-03-31 | $526k | 52k | 10.16 |
| 2020-12-31 | $268k | 36k | 7.45 |
| 2020-09-30 | $52k | 15k | 3.47 |